United States · FDA National Drug Code directory

Carbidopa and levodopa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 42291-472_485d7c0e-be0b-f880-e063-6294a90aacb8
Product NDC: 42291-472
Form: TABLET
Composition / generic term: Carbidopa and levodopa
Labeler: AvKARE
Marketing category: ANDA
Marketing start / end (source format): 20220315
Source listing expiry: 20271231

Source-listed ingredients

CARBIDOPA — 25 mg/1
LEVODOPA — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (42291-472-01) · 42291-472-01
1000 TABLET in 1 BOTTLE (42291-472-10) · 42291-472-10

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →